Preclinical News and Research

RSS
Researchers investigate role of a MYC family gene in ovarian cancer

Researchers investigate role of a MYC family gene in ovarian cancer

Scientific conference on considerations for NBCD regulatory approval pathway

Scientific conference on considerations for NBCD regulatory approval pathway

Karo Bio decides to discontinue development program for eprotirome

Karo Bio decides to discontinue development program for eprotirome

Scientists create new mouse model for medulloblastoma

Scientists create new mouse model for medulloblastoma

Trevena commences TRV130 Phase I clinical trial for severe post-operative pain

Trevena commences TRV130 Phase I clinical trial for severe post-operative pain

Tiltan initiates TL-118 Phase 2 clinical trial for pancreatic cancer

Tiltan initiates TL-118 Phase 2 clinical trial for pancreatic cancer

Regeneron reports total revenues of $123.0M for fourth quarter 2011

Regeneron reports total revenues of $123.0M for fourth quarter 2011

Bexarotene appears to help clear out excess plaque in Alzheimer's

Bexarotene appears to help clear out excess plaque in Alzheimer's

Curcumin may block growth of castrate-resistant prostate tumors

Curcumin may block growth of castrate-resistant prostate tumors

New cERD method can detect RNAi activity in biological fluids

New cERD method can detect RNAi activity in biological fluids

Scientists study a botanical formula that kills aggressive prostate cancer tumors

Scientists study a botanical formula that kills aggressive prostate cancer tumors

Low-dose MNC hUCB therapy effective in ALS-modeled mice

Low-dose MNC hUCB therapy effective in ALS-modeled mice

Soligenix reports positive results from preclinical studies of vaccine thermostabilization technology

Soligenix reports positive results from preclinical studies of vaccine thermostabilization technology

BioLineRx, Genoscience and RFS Pharma enter agreement for BL-8030 Hepatitis C treatment

BioLineRx, Genoscience and RFS Pharma enter agreement for BL-8030 Hepatitis C treatment

Combination of Toca 511 and 5-FC may prolong survival in glioblastoma

Combination of Toca 511 and 5-FC may prolong survival in glioblastoma

New experimental device effectively removes blood clots in stroke patients

New experimental device effectively removes blood clots in stroke patients

EUSA Pharma acquires ASPAREC development and commercialization rights

EUSA Pharma acquires ASPAREC development and commercialization rights

USF receives DOD grant for battlefield-related TBI research

USF receives DOD grant for battlefield-related TBI research

Affinium initiates AFN-1252 Phase 2 trial in acute bacterial skin & skin structure infections

Affinium initiates AFN-1252 Phase 2 trial in acute bacterial skin & skin structure infections

Potential way to block second wave of death from pneumonia treatment

Potential way to block second wave of death from pneumonia treatment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.